Second Sight Medical Products Inc
EYESW · NASDAQ
12/31/2024 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $12,085 | $8,450 | $6,974 | $5,874 |
| - Cash | $18,352 | $69,593 | $3,177 | $11,327 |
| + Debt | $19,313 | $237 | $2,200 | $2,602 |
| Enterprise Value | $13,046 | -$60,906 | $5,997 | -$2,851 |
| Revenue | $0 | $0 | $1 | $3,379 |
| % Growth | -100% | -74% | -100% | – |
| Gross Profit | $0 | $0 | $1 | $1,227 |
| % Margin | – | 50% | 50% | 36.3% |
| EBITDA | -$24,677 | -$8,933 | -$14,896 | -$33,954 |
| % Margin | – | -3,435,769.2% | -1,489,600% | -1,004.9% |
| Net Income | -$23,486 | -$9 | -$15 | -$33,592 |
| % Margin | – | -3,431.2% | -1,488% | -994.1% |
| EPS Diluted | -0.43 | -0 | -0.001 | -1.02 |
| % Growth | -143,233.3% | 40% | 100% | – |
| Operating Cash Flow | -$20,786 | -$9 | -$16,822 | -$27,629 |
| Capital Expenditures | -$556 | -$0 | -$330 | -$493 |
| Free Cash Flow | -$21,342 | -$9 | -$17,152 | -$28,122 |